Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-01

Clinical Trial Update: Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating safety and efficacy of pilocarpine ophthalmic topical cream for presbyopia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pilocarpine ophthalmic topical cream (unspecified brand) (pilocarpine)

Snippet

Sponsor: Glaukos Corporation | Conditions: Presbyopia | Phase 2 | Status: COMPLETED